Botulinum toxin type A is a purified protein used in tiny, controlled doses to temporarily relax specific muscles. Produced by the bacterium Clostridium botulinum, it is the active substance behind well-known injectable brands such as Botox, Dysport and Xeomin. In medical aesthetics it softens the lines created by facial expression; in medicine it treats a range of conditions driven by overactive muscles or nerves. This entry explains the science of the molecule itself—for individual brands, see their own entries.
At a glance
- What it is: A purified neurotoxin protein produced by Clostridium botulinum; one of seven serotypes (A–G)
- What it does: Temporarily blocks nerve-to-muscle signalling, relaxing the targeted muscle
- Mechanism: Cleaves the SNARE protein SNAP-25, preventing acetylcholine release at the neuromuscular junction
- Brands (type A): Botox, Dysport, Xeomin, Nuceiva, Daxxify—their units are not interchangeable
- Onset & duration: Develops over about 2 weeks; lasts roughly 3–4 months for cosmetic use
- Uses: Cosmetic (expression lines) and therapeutic (migraine, hyperhidrosis, muscle disorders)
What is botulinum toxin type A?
Botulinum toxin is a natural protein made by Clostridium botulinum. It exists in seven distinct serotypes, labelled A through G, of which only a few are prepared for medical use.[1] Type A is by far the most widely used in both aesthetics and medicine. In its purified, precisely dosed pharmaceutical form it is not the same as the foodborne illness botulism; it is a controlled medicine given in extremely small, localised amounts to relax a specific muscle for a limited time.
How it works: cleaving SNAP-25
Muscles contract when a nerve releases a chemical messenger called acetylcholine at the point where nerve meets muscle—the neuromuscular junction. Releasing that messenger depends on a set of “SNARE” proteins that let the acetylcholine-filled vesicles fuse with the nerve membrane. Botulinum toxin type A works by cleaving one of these SNARE proteins, SNAP-25, so the vesicles can no longer fuse and release their messenger.[4] With the signal interrupted, the nerve cannot tell the muscle to contract, and the muscle relaxes—an effect known as chemodenervation.[1] Crucially, this is temporary and reversible: over the following months the nerve terminals recover and normal signalling returns.[1]
Type A and the other serotypes
The seven serotypes differ in exactly which SNARE protein they target. Type A (along with types C and E) cleaves SNAP-25, whereas type B (along with D and F) cleaves a different SNARE protein, VAMP, also called synaptobrevin.[4] Types A and B are the ones prepared for clinical use, but type A dominates cosmetic and most therapeutic applications because of its well-studied profile and duration of effect.[1]
The brands of botulinum toxin type A
Botulinum toxin type A is sold under several brand names, each a distinct product with its own nonproprietary (generic) name: Botox (onabotulinumtoxinA), Dysport (abobotulinumtoxinA), Xeomin (incobotulinumtoxinA), Nuceiva (prabotulinumtoxinA) and Daxxify (daxibotulinumtoxinA).[2][3] Although they share the same basic action, they are formulated differently and—importantly—their dosing units are not interchangeable; the units of one product cannot be converted to another.[1][2] A practitioner selects a product and dose based on the treatment area, the goal and their clinical experience.
Cosmetic and therapeutic uses
In aesthetics, botulinum toxin type A softens dynamic wrinkles—lines caused by repeated expression—most commonly frown lines at the glabella, forehead lines and crow’s feet.[2] Because it reduces movement, it is best suited to lines that appear with expression rather than those already etched at rest. Beyond cosmetics, the same molecule is used medically for a wide range of conditions driven by overactive muscles or nerves, including chronic migraine, cervical dystonia, blepharospasm, excessive sweating (hyperhidrosis) and muscle spasticity.[1]
Onset, duration and safety
The effect is not immediate: it typically begins within a few days and develops fully over about two weeks, then lasts roughly three to four months for cosmetic use before gradually wearing off as the nerves recover.[1] Because the effect is temporary, results are maintained with repeat treatment over time. Botulinum toxin type A is a prescription medicine that should be administered only by a qualified, trained healthcare professional; a careful assessment matters because dose and injection points must be tailored to the individual. Common side effects are usually mild and temporary, such as bruising or headache, and it is not suitable for everyone—certain neuromuscular conditions, for example, are contraindications.[2]
Regulation in Canada
In Canada, botulinum toxin type A products are prescription (Schedule D) medicines authorized by Health Canada, each with its own product monograph setting out approved uses, dosing and warnings—Botox and Nuceiva are two examples.[2][3] As prescription drugs, they are subject to Canadian restrictions on advertising to the public, and they may be administered only within an appropriate clinical setting by an authorized health professional.
Related glossary terms
Clinical & editorial sources
- Padda IS, Tadi P. Botulinum Toxin. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated 2023 Nov 6. NBK557387
- AbbVie Corporation. BOTOX COSMETIC (onabotulinumtoxinA) Product Monograph. Health Canada–authorized labelling. abbvie.ca
- Evolus / Clarion Medical. NUCEIVA (prabotulinumtoxinA) Product Monograph. Health Canada. hres.ca
- von Berg L, Stern D, Weisemann J, et al. Optimization of SNAP-25 and VAMP-2 Cleavage by Botulinum Neurotoxin Serotypes A–F. Toxins. 2019;11(10):588. doi:10.3390/toxins11100588
This glossary entry provides general educational information and does not replace an individual clinical assessment or medical advice.
Clinically reviewed by: Leah Zawawi, RPN | Medical Aesthetics & Injectables.
Last reviewed: August 2026.